<qa>  What is the OPTIMAL DOSE OF TOFACITINIB NEEDED toAN EVALUATION OF THE OPTIMAL DOSE OF TOFACITINIB NEEDED TO ACHIEVE LOW DISEASE ACTIVITY LDA OR CLINICAL REMISSION IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS RA AS MEASURED FROM A CLINICAL AND STRUCTURAL PERSPECTIVE: 